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Does TCDD Exposure Alter β7-Integrin Expression on Mouse B Cells?
Sebastian Ramos
Mentor: Gregory DeKrey, Ph.D., Biological Sciences
Abstract: Activated aryl hydrocarbon receptor with ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters
immune responses, including immunoglobulin A (IgA). Manipulation of antibody production via this ligandactivated receptor may provide a novel approach to enhance vaccination in the intestines. The present study aimed
to explain the mechanism responsible for increased levels of fecal IgA in TCDD-treated mice. We hypothesized
that TCDD enhances migration of B cells from non-intestinal tissue to the intestines. Here we predicted that β7integrin, an essential protein for B cell migration into the intestines, would be upregulated by TCDD exposure on
B cells. Female C57BL/6 mice were treated with a single dose of peanut oil (control) or TCDD at 40 µg/kg by
gavage. After 1 week, splenic leukocytes were isolated and analyzed by flow cytometry. B cells in TCDD-treated
mice did not express significantly higher β7-integrin levels than controls, although a significant increase of β7
integrin expression was observed on T cells. These results do not support our hypothesis; yet suggest that elevated
β7 integrin expression allowed for preferential migration of B cells out of the spleen and into the intestines before
analysis. In the future, we plan to address this possibility by examining β7 expression on B cells in the intestines.
Keywords: TCDD, IgA, aryl hydrocarbon receptor, β7-integrin

Mucosal immunity plays an important role
against pathogens and allergies. During mucosal
infections, B cells go through a differentiation
process that allows them to produce antibodies
with high specificity and affinity for the infectious
agents. IgA is one of five types of antibodies
produced by B cells and it is found mainly in
mucosal tissues such as the digestive tract, genital
tract, and respiratory tract. IgA is linked to
regulating commensal microbes in the gut, the
risk of developing allergies, and defenses against
pathogens and toxins (Cerutti, 2008). In the last
three decades, studies on the aryl hydrocarbon
receptor (AhR) have demonstrated altered B cell
function in animals exposed to AhR-activating
chemicals. However, limited research has focused
on how AhR activation can affect IgA-expressing
B cells. That is the focus of this study.

ducts, including but not limited to HIV (Su,
2014).

The significance of the broader work is
directed in hopes to manipulate humoral
responses, such as IgA secretion in mucosal
membranes, via this ligand-induced AhR to
potentially develop vaccines containing
compounds that could maximize the isotype
presence in areas of the body. Manipulation of
antibody production may be the novel approach to
prevent diseases that occur through vocal and
nasal airways, lining of the rectus, or genital

Sufficient production of IgA is essential for
protection against some mucosal-transmitted
microbes; evidence indicates that increased
specific IgA antibody production protects the
body against Helicobacter pylori infection and
suggests that lower levels of IgA allow pathogens
such as H. pylori to colonize the gut with ease
(Srivastava et al., 2013). In a study aiming to
demonstrate the importance of IgA in mucosal
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Significance of IgA
IgA acts as the first line of defense against
pathogens at mucosal membranes in the body of
mammals and is the most abundant antibody
produced (Cerutti, 2008). B cells secrete IgA at
mucosal membranes throughout the body to
protect humans against food-, water-, and airborne
pathogens because the gut and respiratory tract are
the major point of contact with toxins and
pathogens (Mantis, Rol, & Corthesy, 2011). In the
intestines, this particular antibody is mostly
produced by B cells in the lamina propria and
secreted into the lumen of the intestines where it
can also regulate gut microbiota populations and
influence our risk of developing allergies (Wood,
2006).
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membranes of the gut, Uren et.al. (2005) found
that pathogens such as Vibrio cholerae and
influenza virus, localized mainly in the mucosal
areas of the body, seemed to affect body weight
and health recovery in IgA knockout mice more
negatively than those that had IgA-secreting B
cells. Data suggests that the increment of IgA
levels by immunization can prevent infections in
local mucosal areas. For instance, high levels of
fecal anti-cholera toxin B IgA in mice due to
immunization prevented weight loss and lesser
symptoms than those that did not show high levels
of fecal IgA from lack of immunization (Price et
al., 2013).
The role that IgA plays against the human
immunodeficiency virus (HIV) needs further
studying, but sparse research shows the
proprieties of IgA as a mucosal barrier. In a study
done by Su and Moog (2014), IgA levels
increased in HIV- people who interacted with
HIV+ patients, especially in saliva and the genital
tract. The implications of this can lead to the
formation of protective ways to prevent infection
against HIV. However, mechanisms are yet
poorly understood.
AhR-Mediated Biology
The AhR is a ligand-dependent transcription
factor that is known to regulate the expression of
genes important for immune function,
metabolism, cellular homeostasis, and others
(Nebert, Puga, & Vasiliou, 1993). The AhR is
found in most nucleated cells of vertebrates,
including mammals (Okey, 2007). For 30 years,
this receptor has been associated with mediating
chemical toxicity and environmental contaminants
(Stevens, Mezrich, & Bradfield, 2009). In the last
decade, longstanding toxicology studies on 2,3,7,8
tetrachlorodibenzo-p-dioxin (TCDD) have
demonstrated an additional role for this protein in
immunology (Stevens, Mezrich, & Bradfield,
2009).
2,3,7,8 Tetrachlorodibenzo-p-dioxin
A number of different endogenous and
exogenous ligands are known to activate the AhR,
specifically polycyclic aromatic hydrocarbons
(PAHs) (Denison & Nagy, 2003). However,
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TCDD has demonstrated to have the highest
binding affinity out of all compounds related to
AhR and a longer half-life (7-10 days)
(Stejskalova et al., 2011). Much of our
understanding regarding this receptor has been
gleaned from the use of TCDD as it serves as a
model to understand the effects of AhR in the
immune system.
TCDD is a toxic halogenated aromatic
hydrocarbon that forms as a by-product or
contaminant of materials such as 2, 4, 5trichlorophenol (TCP) which is used as an
herbicide (Hay, 1979). The properties of TCDD
limit its risks to direct contact because it is not
volatile. The average U.S. resident has
measureable levels of TCDD in their blood (up to
30 parts per trillion) that come from common
foods sold in U.S. markets (Schecter et. al., 2001);
no study has shown that this level of TCDD
causes adverse effects in humans. However, high
TCDD levels (over 1000-fold) in the skin clearly
lead to adverse health conditions such as
chloracne (a severe form of acne; Forrester et. al.,
2014). Indication that intermediate levels of
TCDD can cause disease in humans is less
convincing because of its weak exposure-effect
relationship. Due to the toxicity of TCDD,
evidence that suggests changes in immune
function in humans is scarce and poorly
understood. Yet, there is ample and extensive
evidence that TCDD exposure alters immune
function, developmental abnormalities, metabolic
disorders, and increases risk of tumor growth in
mice (Baccarelli et al., 2004). In addition to
altering the immune responses, lymphocytes seem
to be particularly sensitive to TCDD exposure
fluctuating their response against pathogens
(Lawrence & Vorderstrasse, 2013). TCDD can
dysregulate B cell differentiation, which causes
suppression of antibody secretion in mice
(Sulentic, Holsapple, & Kaminski, 1998).
AhR-Dependent Immune Function
In regards to immunology, the AhR is a
ligand-dependent transcription factor that
regulates the development and function of the
innate and adaptive immune systems in various
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ways (Zhou, 2016). Activation of the AhR has the
ability to mediate immunological responses
against pathogens with some responses being
suppressed while others augmented. Suppressed
immunity is related to the reduced ability to
appropriately defend against diseases or respond
to vaccination. Augmented immunity is related to
enhanced inflammatory responses or
dysregulation of self-tolerance mechanisms. For
example, one study showed that numerous
cytokines, including IL-6, IL-12, and TNF-α
levels, were reduced upon activation of the AhR,
though fecal IgA levels were increased (Benson &
Shepherd, 2010). Low cytokine levels reduce
inflammation and allows animals to recover
faster. Studies like this are significant to our goal
because animals treated with TCDD showed
markedly reduced severity of autoimmune disease
such as Cronh’s disease, a chronic gastrointestinal
inflammation.
This ligand-mediated activation is most potent
in leukocytes comprising the adaptive immune
system, meaning that a series of signaling
pathways coordinate changes in the responses of
several adaptive leukocytes (Sulentic, Holsapple,
& Kaminski, 1998). Among the most widely
reported impacts of AhR activation is suppression
of IgM and IgG antibody levels (Vorderstrasse et
al., 2003). However, the influence of activated
AhR on IgA antibody levels is not very well
understood.
Studies on humans and laboratory animals
suggest that exposure to AhR-activating
compounds can alter IgA levels in blood and
feces. For instance, a study done on 200
adolescents in Belgium showed that lifetime
exposure to TCDD increased IgA levels in serum
(Van Den Heuvel et al., 2002). Oral exposure in
mice with TCDD suppressed recruitment of CD8+
lymphocytes to the lungs, including decreased
levels of interleukin-12 and decreased antibody
production in the lungs. In addition to those
findings, there was a four-fold increase of IgA in
plasma after TCDD exposure in C57BL/6 mice
(Warren et al., 2000). Similar to those findings,
TCDD exposure affected the transport of IgA to
the liver, which showed an increase of serum IgA
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(Moran et al., 1986). Studies by Ishikawa (2009)
and Kinoshita et al. (2006) found decreased fecal
IgA levels in rodents within the first 3 weeks after
exposure, which suggests a reduced resistance to
food- or water-borne pathogens and toxins.
Limitations from the previously mentioned studies
indicate that circadian rhythm, TCDD dosage,
time, concentration and incubation time, and type
of species, may alter the results.
A handful of studies have looked at the effects
of antibody levels upon treatment with TCDD.
However, a clear consensus understanding
regarding the mechanisms underlying AhR
regulation of IgA production by B cells has yet to
be achieved. Some of these previously mentioned
studies suggested that the increased or decreased
levels of IgA in serum or feces is not due to
increased/reduced antibody production by B cells,
but rather the presence/absence of B cells in the
tissue.
AhR-Mediated B Cell Migration
Migration of lymphocytes, such as B cells, to
the intestinal mucosa requires dimerization of β7
with α4 integrin. A study in 2007, demonstrated
the proposed idea of AhR-mediated migration in
macrophages by exposure of PAHs. PAHs upregulated β7-integrin expression up to 6-fold
factor at mRNA level among other α and β
subunits in both human and mouse primary
macrophages (Monteiro et al., 2007). AhR
involvement was analyzed by using an antagonist
of AhR, which prevented the upregulation of β7integrin in mRNA levels (Monteiro et al., 2007).
These data suggest that TCDD (also an AhR
agonist) may have the same effects on β7-integrin
in B cells, which may lead to an increase rate of
migration into the intestines.
The AhR acts as one of the body’s
environmental detector by binding to a wide
variety of artificial and natural compounds found
in our food. It is important to further understand
the implications that the AhR has in our bodies,
specifically in how our immune system responds
to disease. If we can manipulate humoral
responses, such as IgA secretion in mucosal
membranes, via this ligand-induced receptor, we
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can potentially develop vaccines containing
compounds that could maximize the isotype
presence in areas of the body. Manipulation of
antibody production may be the novel approach to
prevent diseases that occur at mucosal barriers
such as oral and nasal airways, lining of the rectus
or genital ducts, including but not limited to HIV
(Su, 2014).
A previous study in our laboratory has shown
increased levels in fecal IgA upon activation of
the AhR with TCDD exposure in mice (Metten &
DeKrey, 2015). Based on existing literature and
these findings, the purpose of the present study is
to explain the increased levels of fecal IgA after
exposure with TCDD in mice. We hypothesize
that TCDD exposure enhances migration of B
cells from non-intestinal tissue to the lamina
propria of the intestines. If this hypothesis is
supported, we will expect to find an increase in
β7-integrin expression on splenic B cells. In the
present study, we 1) enumerated total number of
leukocytes in the spleen and 2) compared levels of
β7-integrin expression on B cells and T cells with
their respective control groups using flow
cytometry
METHOD
Animals
Female C57BL/6 mice, 6-8 weeks of age,
were obtained from a breeding colony at the
University of Northern Colorado animal facility.
Animals were randomly assigned to one of two
treatment groups and housed on a 12-hour
day/night light cycle. The University of Northern
Colorado Animal Care and Use Committee
approved all protocols for the use of animals in
keeping with current NIH guidelines for animal
usage. Across two replicates, a total of twelve
mice were used, with three mice in each treatment
group (vehicle-treated controls and TCDD-treated
at 40µg/kg) per experiment.
Procedure
Treatment
TCDD was obtained from AccuStandard, Inc.
(Haven, CT). TCDD was dissolved in a vehicle
solution of peanut oil. Vehicle-treated mice
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(control) were only given peanut oil vehicle by
gavage. The TCDD-treated group at 40µg/kg
were given a single dose by gavage. After TCDD
exposure, mice were observed every morning for
1 week to ensure their health.
Cell Preparation
Mice were euthanized via CO2 asphyxiation
from 10 a.m. to 11 a.m. Each spleen was removed
and placed in medium containing DMEM + 1mM
HEPES + 5% heat-inactivated FBS. Cells were
liberated from the spleen by rubbing the tissues
between the frosted ends of microscope slides.
Cells were transferred from the cell suspension
into centrifuge tubes and sedimented at 1300 rpm
for 5 min. Supernatant was discarded and cells
were re-suspended in the same medium.
Erythrocytes were lysed by a 10 second exposure
to water. The remaining cells (leukocytes) were
stained with trypan blue and enumerated under a
microscope using a hemocytometer.
Flow Cytometry
β7-integrin levels on B cells and T cells were
determined using flow cytometry technique. The
following antibodies were used to stain cells:
Fluorescein-isothiocyanate (FITC)-conjugated
anti-mouse β7-integrin (clone 11-44-2) or IgG1
isotype control (clone KLH/G1-2-2); Alexa Fluor
647 (AF647)-conjugated anti-mouse CD19 (clone
RA3-6B2), -conjugated anti-mouse CD3 (clone
RA3-6B2), or IgG1 isotype control (clone RA36B2). Antibodies were purchased from Southern
Biotech (Birminghan, AL) or BD PharMingen
(San Jose, CA). Cells were analyzed on a BD
Accuri C6 flow cytometer (San Jose, CA). A
minimum of 18,000 cumulative events were
collected per sample. A cell was considered
positive (+) for expression of a marker if its
fluorescence was greater than the fluorescence of
the corresponding non-stained or isotype controlstained cell population. Lymphocytes (based on
90° light scatter versus FSC gating) were
considered viable if they were negative for 7AAD fluorescence. Only single cells (based on
integrated versus peak FSC) were considered for
analysis.
Statistical Analysis
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The data were analyzed by two-way analysis
of variance (ANOVA) and SigmaPlot statistical
software. Sources of variation (effects) for the
statistical model included the experiment number
and the dose of TCDD. All-pairwise post-hoc ttests were used to determine differences between
means. Each experiment was replicated a
minimum of two times to ensure consistency of
results. Values of p ≤ 0.05 were considered
significant.
RESULTS
Statistical analysis was only based on TCDD
source of variation and not on experiment nor
experiment x TCDD interaction because the
differences in mean values were not significant. In
control mice, body weight ranged between 17-21
g and was not significantly changed in
comparison to the TCDD-treated group.
Thymuses were observed to be smaller in TCDDtreated mice (as reported by Metten & DeKrey,
2015), and was considered a positive indicator of
TCDD exposure. When compared to controls, the
total number of splenic leukocytes in TCDDtreated mice was significantly reduced (F(1,8) =
12.254, p = 0.008). In contrast, the percentages of
B cells and T cells in spleens were not altered by
TCDD exposure with approximately 60% being B
cells and 40% being T cells (see fig. 2A). The
percentage of CD3+ or CD19+ cells expressing
β7-integrin was not significantly different
between control and TCDD-treated mice. The
mean fluorescence for β7-integrin on CD19+ cells
was not significantly different between control
and TCDD-treated groups. The mean
fluorescence for β7-integrin on CD3+ TCDDtreated cells, however, showed a significant
increase in comparison to control (F(1,8) = 6.998,
p = 0.029).

Figure 2. (A) Total percentage of CD19+ and CD3+
cells in the spleens at both zero, and 40 µg/Kg TCDD.
(B) Mean fluorescence of FL1 depicts the mean
expression of β7-integrin on both CD19+ and CD3+ at
both 0 and 40 µg/Kg of TCDD. Splenic leukocytes
were stained with AF647 (FL4) for anti-CD19 and
anti-CD3 cells and FITC (FL1) for anti-β7-integrin.
Β7-integrin levels were then analyzed using flow
cytometry. Data are the means ± SD of two combined
trials; they are shown comparatively to the value of
β7-integrin levels found in control cells. *p < 0.05.

A

Figure 1. Total number of splenic leukocyte at both 0
and 40 ug/kg of TCDD. After isolation of splenic
leukocytes, cells were counted using hemocytometers.
Viability was shown by using trypan blue. Data are the
means ± SD of two combined trials; they are shown
comparatively to the value of β7-integrin levels found
in control cells. *p < 0.05.

Published by Scholarship & Creative Works @ Digital UNC, 2019

5

Ursidae: The Undergraduate Research Journal at the University of Northern Colorado, Vol. 7, No. 2 [2019], Art. 8

B

DISCUSSION
In the present study, we were unable to
demonstrate that TCDD exposure enhances B
cells migration by increasing β7-integrin
expression on B cells. These results suggest that
elevation of fecal IgA levels in TCDD-treated
mice may be caused by a different mechanism. On
the other hand, data showed significantly
increased average β7-integrin expression on CD3+
cells from TCDD-treated mice indicating that
TCDD exposure does impact β7-integrin
expression on some cells. Interestingly, TCDD
exposure significantly reduced total leukocyte
numbers in spleens. Although a direct explanation
for this change in leukocyte numbers is not
provided by the results of this study, one
possibility is that TCDD exposure on day 0
caused an increase of β7-integrin expression on B
cells (and other cells) which allowed for B cell
migration to the intestines prior to analysis on day
7. This particular information suggests that
leukocytes did migrate out of the spleen into other
tissues. We cannot say with certainty that these
cells migrated into the intestines, but future
studies may demonstrate so by directing their
focus to collecting the spleens at different times or
analyzing intestinal tissue instead. A high percent
of interest should be placed by future researchers
into understanding the effects of circadian rhythm
on antibody levels if we wish to understand the
implications of the AhR on IgA. The circadian
rhythm has demonstrated to have an effect on
antibody levels, which could aid in the
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understanding of B cell migration (Garrett &
Gasiewicz, 2006). Our data suggest that B cells
may have already migrated to the intestines or
other tissues and that is why we did not obtain
high levels of β7-integrin expression.
The unchanged percentage of CD19+ and
CD3+ cells across control and treated groups (fig
2A) may suggest that there was no B cell
migration at all. However, readers should see this
figure as an indicator of the body’s effort toward
achieving homeostasis as it encounters xenobiotic
compounds like TCDD. The figure does not
account for migration because it is only showing
percentages and not total numbers. The total
number may change without necessarily yielding
a different ratio.
Some limitations of the study include: (a) the
time at which spleens were collected may have
been a time when B cells had already migrated
into the intestines; (b) the number of trials
performed does not rule out the probability of
random results; (c) we did not find a well-known
range of β7-integrin levels in the literature for us
to know how much was necessary to create a
migration response; and (d) after we finished
collecting our data, we received an email from BD
that some of the antibodies we had purchased
were being recalled for not working. In addition to
that, TCDD and mice acting as models to study
the AhR can be very valuable to understanding
mechanisms and its effects in humans. However,
it is necessary to understand the differences
between mice and humans in regards to the AhR
pathways, which are acknowledged by the authors
but were not be investigated in this study.
The AhR acts as the body’s environmental
detector by binding to a wide variety of artificial
and natural compounds found in places such as
our own grocery stores. It is important to further
understand the implications that the AhR has in
our bodies, specifically in how our immune
system responds to disease. More studies must be
done to understand the mechanisms behind the
AhR and IgA. Topics that are important to take
into consideration for future studies are
consolidating the period of time that takes TCDD
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to cause effects in the body, the time of collection
due to changes in antibody levels affected by the
circadian rhythm of mice, and the usage of
different ligands to exert different responses in
mouse models. Our study takes the first steps
towards understanding the mechanisms behind
AhR-mediated migration of B cells into the
intestines. AhR activation shows to be capable of
mediating the migration of splenic leukocyte to
other tissues of the body, which can explain
altered levels of antibodies in the intestines such
as IgA. However, more research must be done in
order to accurately show the mechanism for
increased levels of fecal IgA.
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